- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2007
- Public Summary Document (PSD) March 2007 PBAC Meeting - PDF
Dasatinib – March 2007
Dasatinib, tablets, 20 mg, 50 mg and 70 mg, Sprycel®, March 2007
Last updated
29 June 2007